Uncovering the Power of Machine Learning for Advancing Drug Development of Divalent SiRNAs to Treat Neurological Diseases
Time: 1:30 pm
day: Day Two
Details:
- Leveraging a computational algorithm for designing and prioritizing siRNA constructs to take forward as lead candidates
- Taking advantage of computational tools, machine learning and proprietary scoring models for identifying therapeutically relevant siRNAs for treatment of neurodegenerative treatments
- Harnessing computational strategies for target prioritization and understanding RNAs expressed in target tissues
